BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15691503)

  • 1. Quantitative nuclear magnetic resonance analysis and characterization of the derivatized Haemophilus influenzae type b polysaccharide intermediate for PedvaxHIB.
    Xu Q; Klees J; Teyral J; Capen R; Huang M; Sturgess AW; Hennessey JP; Washabaugh M; Sitrin R; Abeygunawardana C
    Anal Biochem; 2005 Feb; 337(2):235-45. PubMed ID: 15691503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An NMR spectroscopic identity test for the control of the capsular polysaccharide from Haemophilus influenzae type b.
    Lemercinier X; Jones C
    Biologicals; 2000 Sep; 28(3):175-83. PubMed ID: 10964444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity characterization of bromoacetyl derivatized polyribosylribitol polysaccharide in Haemophilus influenzae type b for PedvaxHIB® by NMR spectroscopy.
    Rustandi RR; Xu Q
    Vaccine; 2022 Jan; 40(2):187-191. PubMed ID: 34893342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability testing in Haemophilus influenzae type b conjugate vaccines.
    Klug B
    Dev Biol Stand; 1996; 87():263-7. PubMed ID: 8854026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple and rapid method for measuring unconjugated capsular polysaccharide (PRP) of Haemophilus influenzae type b in PRP-tetanus toxoid conjugate vaccine.
    Guo YY; Anderson R; McIver J; Gupta RK; Siber GR
    Biologicals; 1998 Mar; 26(1):33-8. PubMed ID: 9637747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a high-resolution magic-angle spinning nuclear magnetic resonance identity assay of the capsular polysaccharide from Haemophilus influenzae type b present in cetavlon precipitate.
    Wieruszeski JM; Talaga P; Lippens G
    Anal Biochem; 2005 Mar; 338(1):20-5. PubMed ID: 15707931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proton magnetic resonance determination of N,N-dimethylformamide in one intermediate of the Quimi-Hib vaccine.
    Garrido Arteaga R; Cardoso San Jorge F; Rodríguez Montero Mdel C; Fernández Santana V; Vérez Bencomo V; Vélez Castro H
    Magn Reson Chem; 2012 Aug; 50(8):525-8. PubMed ID: 22730256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
    Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPAEC-PAD method for the analysis of alkaline hydrolyzates of Haemophilus influenzae type b capsular polysaccharide.
    de Haan A; van der Put RM; Beurret M
    Biomed Chromatogr; 2013 Sep; 27(9):1137-42. PubMed ID: 23681893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1252-5. PubMed ID: 19023262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
    Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
    Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring bromide loss in bromoacetyl-derivatized polyribosylribitol polysaccharide in Haemophilus influenzae type b for PedvaxHIB® by capillary electrophoresis and NMR spectroscopy.
    Rustandi RR; Hamm M; Onimus M; Yuan Y; Anderson CL; Zong C
    Vaccine; 2022 Oct; 40(42):6012-6016. PubMed ID: 36123258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the saccharide content and stability of the first WHO International Standard for Haemophilus influenzae b capsular polysaccharide.
    Mawas F; Bolgiano B; Rigsby P; Crane D; Belgrave D; Corbel MJ
    Biologicals; 2007 Oct; 35(4):235-45. PubMed ID: 17337205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemophilus influenzae type b conjugate vaccine stability: catalytic depolymerization of PRP in the presence of aluminum hydroxide.
    Sturgess AW; Rush K; Charbonneau RJ; Lee JI; West DJ; Sitrin RD; Hennessy JP
    Vaccine; 1999 Mar; 17(9-10):1169-78. PubMed ID: 10195629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interim recommendations for the use of Haemophilus influenzae type b (Hib) conjugate vaccines related to the recall of certain lots of Hib-containing vaccines (PedvaxHIB and Comvax).
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Dec; 56(50):1318-20. PubMed ID: 18097345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
    Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D
    Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The determination of phosphorus in Haemophilus influenzae type b conjugate vaccines by inductively coupled plasma-atomic emission spectrometry.
    Swartz LA; Progar JJ; May JC
    Biologicals; 2000 Dec; 28(4):227-31. PubMed ID: 11237358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Validation of an ELISA assay for the quantification of antibodies against Haemophilus influenzae type b capsular polysaccharide].
    Toraño Peraza G; Hernández Vadell I; Baly A; Toledo Romaní ME
    Rev Cubana Med Trop; 2005; 57(3):185-91. PubMed ID: 17969271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fully liquid diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis--Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants.
    Lin TY; Wang YH; Chang LY; Huang YC; Kao HT; Lin PY; Lu HK; Chavand P; Ortiz E
    Int J Infect Dis; 2007 Mar; 11(2):129-36. PubMed ID: 16762579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoconjugate vaccines against Haemophilus influenzae type b.
    Fernandez Santana V; Peña Icart L; Beurret M; Costa L; Verez Bencomo V
    Methods Enzymol; 2006; 415():153-63. PubMed ID: 17116473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.